Board of Directors
Co-founder and CEO
Mr. Hoffmann is entirely dedicated to the development of Network Immunology's systems biology approach to treating disease and optimizing health. Realizing the immense untapped value in the systems biology, and more specifically, immune network approach to understanding immuno-regulation, George Hoffmann co-founded Network Immunology with Chief Scientist, Dr. Geoffrey W. Hoffmann in 2003. In 2007, Hoffmann was appointed Manager of Business Development. In 2009, at a key juncture in the Company’s history, he was appointed President and CEO. Since then he has been a major driver behind the Company's development and expansion.
Dr. Hoffmann obtained his PhD (Dr. rer. nat.) in 1972 from the Technische Universität Braunschweig as a student of Professor Manfred Eigen for research done at the Max Planck Institut für Biophysikalische Chemie in Göttingen, Germany. He began his research on immune network theory in 1974 at that Institute.
Co-inventor, Technology Developer
Dr. Gorczynski works with Dr. Geoffrey Hoffmann on the development of AbstimX™. As both an MD and PhD, Dr. Gorczynski brings an extensive understanding of medicine, from laboratory research, discovery and development, through to patient administration. Dr. Gorczynski was professor in the Department of Surgery at the Toronto Hospital, University Health Network, as well as professor in the Department of Immunology at the University of Toronto. His primary interests and expertise are in adaptive immunity, the regulation of tumor growth/metastasis and the regulation of transplant rejection.